Arecor Therapeutics PLC
LSE:AREC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
A
|
Apollo Endosurgery Inc
F:HQ8F
|
US |
|
C
|
Chanson International Holding
NASDAQ:CHSN
|
CN |
|
L
|
LT Group Inc
XPHS:LTG
|
PH |
|
C
|
Clarus Corp
NASDAQ:CLAR
|
US |
|
J
|
Jaeyoung Solutec Co Ltd
KOSDAQ:049630
|
KR |
|
F.C.C. Co Ltd
TSE:7296
|
JP |
|
Sonos Inc
NASDAQ:SONO
|
US |
Wall Street
Price Targets
AREC Price Targets Summary
Arecor Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for AREC is 281.01 GBX with a low forecast of 253.51 GBX and a high forecast of 315 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AREC's stock price target?
Price Target
281.01
GBX
According to Wall Street analysts, the average 1-year price target for AREC is 281.01 GBX with a low forecast of 253.51 GBX and a high forecast of 315 GBX.
What is Arecor Therapeutics PLC's Revenue forecast?
Projected CAGR
-44%
For the last 7 years the compound annual growth rate for Arecor Therapeutics PLC's revenue is 21%. The projected CAGR for the next 3 years is -44%.
